---
id: who-tb-prevention-2024
title: "WHO Consolidated Guidelines on Tuberculosis: Module 1 - Tuberculosis Preventive Treatment (Second Edition)"
short_title: "WHO TB Prevention 2024"

organization: World Health Organization
collaborators: null
country: null
url: https://www.who.int/publications/i/item/9789240096196
doi: null
pmid: null
open_access: true

specialty: infectious-disease
guideline_type: clinical-practice
evidence_system: GRADE
conditions:
  - tuberculosis
  - latent TB infection
  - TB prevention
tags:
  - isoniazid
  - rifampicin
  - rifapentine
  - TPT
  - MDR-TB contacts
  - LTBI

publication_date: 2024-09-09
previous_version_date: 2020-03-24
status: current
supersedes: who-tb-prevention-2020
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-21
---

## Scope

Updated WHO recommendations for tuberculosis preventive treatment (TPT) including regimens, target populations, and management of contacts of multidrug-resistant TB.

## Notes

Part of WHO's modular consolidated TB guidelines. 2024 update includes new strong recommendation for levofloxacin daily for 6 months as TPT option for MDR/RR-TB contacts.
